Search Results - "HELENA GARCIA, M"
-
1
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand
Published in European journal of medicinal chemistry (01-02-2019)“…Two new ruthenium complexes, [Ru(η5-Cp)(PPh3)(2,2’-bipy-4,4’-R)]+ with R = -CH2OH (Ru1) or dibiotin ester (Ru2) were synthesized and fully characterized. Both…”
Get full text
Journal Article -
2
A new family of iron(II)-cyclopentadienyl compounds shows strong activity against colorectal and triple negative breast cancer cells
Published in Molecules (Basel, Switzerland) (30-03-2020)“…The following is available online, Figure S1—1H NMR spectrum of complexes 6, in acetone-d6, Table S1. Bond lengths [Å] and angles [°] for…”
Get full text
Journal Article -
3
Ruthenium–Cyclopentadienyl Bipyridine–Biotin Based Compounds: Synthesis and Biological Effect
Published in Inorganic chemistry (15-07-2019)“…Prospective anticancer metallodrugs should consider target-specific components in their design in order to overcome the limitations of the current…”
Get full text
Journal Article -
4
Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods
Published in Biometals (01-10-2021)“…The interaction between human serum transferrin (hTf) and three promising organometallic Ru (II)- (η 5 -C 5 H 5 ) derived complexes, that have already shown…”
Get full text
Journal Article -
5
Polymer “ruthenium-cyclopentadienyl” conjugates - New emerging anti-cancer drugs
Published in European journal of medicinal chemistry (15-04-2019)“…In this work, we aimed to understand the biological activity and the mechanism of action of three polymer-‘ruthenium-cyclopentadienyl’ conjugates (RuPMC) and a…”
Get full text
Journal Article -
6
In Vivo Performance of a Ruthenium-cyclopentadienyl Compound in an Orthotopic Triple Negative Breast Cancer Model
Published in Anti-cancer agents in medicinal chemistry (2017)“…Ruthenium-based anti-cancer compounds are proposed as viable alternatives that might circumvent the disadvantages of platinum-based drugs, the only…”
Get more information
Journal Article -
7
New copper(I) and heteronuclear copper(I)–ruthenium(II) complexes: Synthesis, structural characterization and cytotoxicity
Published in Journal of inorganic biochemistry (01-04-2017)“…A new family of copper(I) complexes of general formula [Cu(dppe)(NN)]+ have been synthesized and fully characterized, with…”
Get full text
Journal Article -
8
Methyl-cyclopentadienyl Ruthenium Compounds with 2,2′-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential
Published in Inorganic chemistry (16-04-2018)“…New ruthenium methyl-cyclopentadienyl compounds bearing bipyridine derivatives with the general formula [Ru(η5-MeCp)(PPh3)(4,4′-R-2,2′-bpy)]+ (Ru1, R = H;…”
Get full text
Journal Article -
9
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
Published in Journal of biological inorganic chemistry (01-08-2014)“…A set of structurally related Ru(η 5 -C 5 H 5 ) complexes with bidentate N,N′-heteroaromatic ligands have been evaluated as prospective metallodrugs, with…”
Get full text
Journal Article -
10
Biotinylated polymer-ruthenium conjugates: in vitro and in vivo studies in a triple-negative breast cancer model
Published in Pharmaceutics (30-06-2022)“…The need for new therapeutic approaches for triple-negative breast cancer is a clinically relevant problem that needs to be solved. Using a multi-targeting…”
Get full text
Journal Article -
11
Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells
Published in European journal of medicinal chemistry (01-01-2018)“…Three new compounds have been synthesized and completely characterized by analytical and spectroscopic techniques. The new bipyridine-perfluorinated ligand L1…”
Get full text
Journal Article -
12
Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer
Published in Dalton transactions : an international journal of inorganic chemistry (14-05-2020)“…In this work we explored the possibility of improving the selectivity of a cytotoxic Ru complex [RuCp(PPh )(2,2'-bipy)][CF SO ] (where Cp = η…”
Get more information
Journal Article -
13
Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites
Published in Journal of inorganic biochemistry (01-12-2015)“…Searching for new prospective antitrypanosomal agents, three novel Ru(II)-cyclopentadienyl compounds, [Ru(η5-C5H5)(PPh3)L], with HL=bioactive 5-nitrofuryl…”
Get full text
Journal Article -
14
[RuII(η5-C5H5)(bipy)(PPh3)]+, a promising large spectrum antitumor agent: Cytotoxic activity and interaction with human serum albumin
Published in Journal of inorganic biochemistry (01-12-2012)“…Ruthenium complexes hold great potential as alternatives to cisplatin in cancer chemotherapy. We present results on the in vitro antitumor activity of an…”
Get full text
Journal Article -
15
Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes
Published in Journal of inorganic biochemistry (01-03-2017)“…Two recently published Ru(III) complexes bearing (N2O2) tetradentate bis(aminophenolate) ligands, formulated as [Ru(III)(salan)(PPh3)Cl] (salan is the…”
Get full text
Journal Article -
16
New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
Published in Journal of inorganic biochemistry (01-01-2014)“…A novel water soluble organometallic compound, [RuCp(mTPPMSNa)(2,2′-bipy)][CF3SO3] (TM85, where Cp=η5-cyclopentadienyl,…”
Get full text
Journal Article -
17
The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds
Published in Journal of inorganic biochemistry (01-09-2015)“…A new family of eight ruthenium(II)-cyclopentadienyl bipyridine derivatives, bearing nitrogen, sulfur, phosphorous and carbonyl sigma bonded coligands, has…”
Get full text
Journal Article -
18
Exploring the effect of the ligand design on the interactions between [Ru(η5-C5H5)(PPh3)(N,O)][CF3SO3] complexes and human serum albumin
Published in Journal of inorganic biochemistry (01-12-2013)“…Ruthenium complexes hold a great potential in chemotherapy as an alternative to the classical platinum based drugs. The organometallic compounds studied in the…”
Get full text
Journal Article -
19
Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex
Published in Journal of inorganic biochemistry (01-05-2013)“…Anticancer activity of the new [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] (Me2bpy = 4,4′-dimethyl-2,2′-bipyridine) complex was evaluated in vitro against several…”
Get full text
Journal Article -
20
Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands
Published in Journal of inorganic biochemistry (01-03-2009)“…Inhibition of the growth of LoVo human colon adenocarcinoma and MiaPaCa pancreatic cancer cell lines by two new organometallic ruthenium(II) complexes of…”
Get full text
Journal Article